Illumina
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
Latest Content
eBook
Simplify Your Sequencing: A Guide to Accessible Genomic Discovery
This eBook highlights how benchtop sequencing simplifies workflows, lowers barriers and expands research opportunities.
Product News
Alnylam Pharmaceuticals Joins Alliance for Genomic Discovery, Expanding Diverse Clinical Genomic Dataset To Drive Precision Medicine
Alnylam joins Illumina and NashBio’s Alliance for Genomic Discovery to expand its 250,000 genome dataset and fuel RNAi research.
Industry Insight
Whole-Genome Sequencing Enables Rare Variant Discovery at Scale
Illumina’s Rami Mehio discusses the whole-genome sequencing of 490,640 UK Biobank participants with Molly Coddington for Technology Networks.
Product
Advertisement
NovaSeq X Series: Optimized for Comprehensive Omic Solutions
The NovaSeq X Series offers scalable, high-throughput sequencing for genome, epigenome, transcriptome, and proteome analysis, enabling broad, flexible multiomics research and deeper biological insights.
eBook
Redefining the Impossible With Genomics
This eBook explores how researchers are dismantling these barriers by harnessing deeper sequencing, richer data and smarter workflows to unlock breakthroughs across population health, cancer biology and molecular diagnostics.
eBook
Streamline Somatic Variant Interpretation
Discover how the Connected Insights can streamline user-defined variant interpretation research workflows and reduce the time it takes to generate meaningful insights, all with a single-vendor workflow.
Product
Advertisement
Illumina Connected Insights
Unlock insights with NGS tertiary analysis software
eBook
Break Through the NGS Interpretation Bottleneck To Improve Patient Outcomes
This eBook explores how to enhance throughput while maintaining high-quality variant analysis and reporting.
Webinar
Simultaneous Profiling of the Epigenome and Transcriptome at a Single-Cell Level
On-Demand
In this webinar, you’ll learn about the insights you could gain by profiling gene expression and open chromatin from the same cell simultaneously.
Product News
New State-of-the-Art Genomic Services Facility Opening in the UK
Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024.
Advertisement
